Clinical Trial

Looking for a Blood Epigenetic Signature to Predict Female Infertility

Study acronym: FIB_CARIPLO
Recruiting
View on ClinicalTrials.gov →
Summary
The present research project aims to study the DNAm mechanisms underlying the reduction of fertility due to the progressive depletion of oocyte quality. Specifically, our project aims to build an epigenetic clock for MGCs by using outcomes that are certainly related to female fertility. The validation of such findings will be carried out on peripheral blood in order to guarantee its non-invasiveness and allow for any clinical transferability. In order to identify a blood epigenetic signature able to predict female infertility, we planned to explore the problem from different points of view by conducting several studies in different settings.
Trial Details
NCT Number NCT06098495
Lead Sponsor Università Vita-Salute San Raffaele
Conditions Female Infertility
Enrollment 1,456 participants
Start Date 2023-10-16
Primary Completion 2026-10-16 (estimated)
Study Completion 2026-10-16 (estimated)
Updated on ClinicalTrials.gov 2023-10-24